Phase

n/a (69,478)

phase 2 (24,085)

phase 3 (17,840)

phase 4 (13,868)

phase 1 (13,866)

phase 1/phase 2 (5,788)

phase 2/phase 3 (2,782)

early phase 1 (1,798)

Funder Type

Other (129,857)

Industry (42,248)

NIH (4,551)

U.S. Fed (2,097)

Study Type

Interventional (149,531)

Observational (25,540)

Observational [Patient Registry] (3,561)

Expanded Access (121)

5,10-methylenetetrahydrofolate

Showing 1 - 25 of >10,000

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Osteosarcoma Trial in Worldwide (Calcium Folinate, [6R] 5,10-methylenetetrahydrofolate (arfolitixorin))

Completed

Has Results

Osteosarcoma

Calcium Folinate
[6R] 5,10-methylenetetrahydrofolate (arfolitixorin)

Brno, Czechia
+4 more

Sep 7, 2020

Rectal Cancer Trial in Göteborg ([6R] 5,10-methylenetetrahydrofolate (arfolitixorin), Pemetrexed)

Completed

Rectal Cancer

[6R] 5,10-methylenetetrahydrofolate (arfolitixorin)
Pemetrexed

Göteborg, Sweden

Sahlgrenska University Hospital

Sep 7, 2020

Colonic Tumors Trial in Gothenburg (6R-MTHF (arfolitixorin) 200 mg/m2, Levoleucovorin 200 mg/m2, 6R-MTHF (arfolitixorin) 60

Completed

Has Results

Colonic Neoplasms

6R-MTHF (arfolitixorin) 200 mg/m2
+3 more

Gothenburg, Sweden

Sahlgrenska University Hospital

Sep 7, 2020

C677T Methylenetetrahydrofolate Reductase Mutation

Completed

Mutation

infertily evaluation

(no location specified)

May 16, 2023

Colorectal Tumor Trial in Worldwide (Modufolin (arfolitixorin), Fluorouracil, Oxaliplatin)

Completed

Colorectal Neoplasm

Modufolin (arfolitixorin)
+4 more

Odense, Denmark
+9 more

Sep 7, 2020

Cholecystitis; Gallstone, Cholecystolithiasis, Cholecystitis, Chronic Trial in Aswan (5-5-5-8 technique, 10-10-10-5 technique)

Recruiting

Cholecystitis; Gallstone
+2 more

5-5-5-8 technique
10-10-10-5 technique

Aswan, Egypt

Aswan University Hospital

Sep 20, 2023

Bioequivalence Trial in Moscow (Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg

Recruiting

Bioequivalence

Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet

Moscow, Russian Federation

Ligand Research LLC

Jul 7, 2023

Colorectal Cancer Metastatic Trial in Adelaide (CNA3103: 5 x 10^7 cells, CNA3103: 1.5 x 10^8 cells, CNA3103: 4.5 x 10^8 cells)

Not yet recruiting

Colorectal Cancer Metastatic

CNA3103: 5 x 10^7 cells
+4 more

Adelaide, South Australia, Australia

Carina Biotech Investigators

Feb 26, 2023

Diabetes Type 2 Trial in Seongnam (Dapagliflozin 10mg Tab, Lobeglitazone 0.5 mg, Dapagliflozin + Lobeglitazone)

Recruiting

Diabetes Type 2

Dapagliflozin 10mg Tab
+2 more

Seongnam, Gyeonggi, Korea, Republic of

Seoul National University Bundang Hospital

Jun 14, 2023

Hypercholesterolemia, Dyslipidemia Trial in Seoul (Ezetimibe/Atorvastatin 10/5 mg, Atorvastatin 5mg, Ezetimibe 10mg)

Completed

Hypercholesterolemia, Dyslipidemia

Ezetimibe/Atorvastatin 10/5 mg
+7 more

Seoul, Korea, Republic of

Seoul National University Hospital

Jul 24, 2023

Keloid Trial (Ethosomal gel bearing losartan 5%, triamcinolone acetonide 10 mg/ml)

Not yet recruiting

Keloid

Ethosomal gel bearing losartan 5%
triamcinolone acetonide 10 mg/ml

(no location specified)

Jun 5, 2023

Scabies Trial in Abbottabad (Permethrin, Sulphur)

Completed

Scabies

Abbottābād, Khyber Pakhtunkhawa, Pakistan

CMH Abbottabad

May 8, 2023

Healthy Trial (Daridorexant 10 mg, Daridorexant 25 mg)

Not yet recruiting

Healthy

Daridorexant 10 mg
Daridorexant 25 mg

(no location specified)

Jun 1, 2023

Essential Hypertension Trial (Nerkardou 5 mg & Nerkardou 10 mg)

Not yet recruiting

Essential Hypertension

Nerkardou 5 mg & Nerkardou 10 mg

(no location specified)

May 30, 2023

Bioequivalence, Healthy Subjects Trial in Amman (PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg

Completed

Bioequivalence
Healthy Subjects

PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg amlodipine tablets
TRIPLIXAM® 10 mg /2.5 mg/10 mg, 10 mg perindopril arginine / 2.5 mg indapamide / 10 mg amlodipine film-coated tablets

Amman, Jordan

International Pharmaceutical Research Center

Jul 20, 2022

Hyperkalemia, Potassium Imbalance, Electrolyte Imbalance Trial in Seeb (Insulin regular, Dextrose 50, salbutamol)

Not yet recruiting

Hyperkalemia
+3 more

Insulin regular
+2 more

Seeb, Muscat, Oman

Sultan Qaboos University hospital

Sep 11, 2023

Diabetic Foot Infection Trial (5% Nu-3 gel, 10% Nu-3 gel, Placebo)

Not yet recruiting

Diabetic Foot Infection

5% Nu-3 gel
+2 more

(no location specified)

Aug 27, 2023

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

Recruiting

Hematologic Malignancy
Stem Cell Transplant Complications

Beijing protocol

Beijing, Beijing, China

Deparment of Hematology, Peking University People's Hospital

Jun 19, 2023

Retinitis Pigmentosa Trial (1.5 x 10^6 UC-MSC + CM, 5 x 10^6 UC-MSC + CM)

Not yet recruiting

Retinitis Pigmentosa

1.5 x 10^6 UC-MSC + CM
5 x 10^6 UC-MSC + CM

(no location specified)

Jun 11, 2023

Amlodipine/Atorvastatin/Perindopril Single Pill Combination

Not yet recruiting

Arterial Hypertension
HTN

Amlodipine 5 mg + atorvastatin 10 mg + perindopril arginine 5 mg
+2 more

(no location specified)

Mar 1, 2023

Molluscum Contagiosum Trial in Abbottabad (potassium hydroxide)

Completed

Molluscum Contagiosum

potassium hydroxide

Abbottabad, KPK, Pakistan

CMH

Nov 22, 2022

Bioequivalence, Healthy Subjects Trial in Amman (PERINDOPRES® DUO 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets,

Completed

Bioequivalence
Healthy Subjects

PERINDOPRES® DUO 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets
Noliterax® 10 mg/2.5 mg 10 mg perindopril arginine / 2.5 mg indapamide film-coated tablets